This review discusses pharmacological strategies to manage sympathetic hyperactivity in hypertensive patients to improve cardiovascular prognosis.
Sympathetic modulation strategies in hypertension merit prospective evaluation; leaves open optimal agents and clinical adoption.
The second part of the review considers different classes of drugs affecting blood pressure in increased activity of the sympathetic nervous system. Additional possibilities are discussed on how to reduce the negative effect of sympathetic hyperactivity on cardiovascular system and improve the prognosis.
No takes yet. Share an insight, caveat, or question.
Safaryan et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: